UMass Medical School scientist Gang Han, PhD, and his team have designed a new class of molecules used in photodynamic therapy that are able to direct lamp light deep into tissue to kill cancer tumors. In a new paper published … Read More »
Nanoscale fluorescent probes that switch on in the presence of cancer cells helped surgeons remove tumours in mice without harming healthy tissue, according to a study published Monday. The potentially breakthrough technology works for all kinds of cancers, the researchers … Read More »
Women today are choosing to have children later in life than ever before. Egg freezing, technically known as oocyte cryopreservation, can enable a woman to delay pregnancy until a later stage. In 1980, the average American woman had her first … Read More »
Electronic-skin prototypes are stretchy, thin films that can sense temperature, pressure and even monitor blood oxygen or alcohol levels. But most of these devices are missing a key feature of real skin that allows us to feel a wider range … Read More »
Engineers at the University of California San Diego have developed a new non-invasive method to detect infections in prostheses used for amputees, as well as for knee, hip and other joint replacements. The method, which is at the proof of … Read More »
By Steven Reinberg HealthDay Reporter MONDAY, Dec. 12, 2016 (HealthDay News) — One in six U.S. adults takes a psychiatric medication to cope with conditions such as depression, anxiety and insomnia, a new study finds. Researchers found that in 2013 … Read More »
Before the new Congress and incoming Trump administration act to repeal the Affordable Care Act, the Obama administration is pushing forward with two new reforms authorized by the ACA. Both are meant to increase patient engagement of Medicare beneficiaries. Thursday, the … Read More »
With the number of people living with Alzheimer’s disease expected to almost triple by 2050, the race is on to find a treatment that can prevent or slow the condition. But last week saw another crack emerge in the already … Read More »
The CAR-T field can rest easy, reassured by Wednesday’s positive interim results from bluebird bio’s Phase 1 dose escalation study in relapsed/refractory multiple myeloma. The news comes just one week after its competitor Juno Therapeutics disclosed the death of two … Read More »
Determining which medication is ideal for treating a patient’s unique cancer is usually a hit-and-miss affair. A drug is tried and then the tumor monitored for changes. If it works the patient is kept on the same medication, but if … Read More »